XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue $ 7,363 $ 24,036 $ 14,500 $ 109,190
Operating expenses        
Research and development 19,959 25,940 62,867 88,768
General and administrative 10,334 9,638 31,510 29,074
Total operating expenses 30,293 35,578 94,377 117,842
Operating loss (22,930) (11,542) (79,877) (8,652)
Other income (expense):        
Change in fair value of equity investment   274   274
Loss from equity method investment (1,783)   (4,183)  
Interest expense (405) (55) (625) (79)
Interest income 1,172 44 1,536 145
Total other income (expense), net (1,016) 263 (3,272) 340
Net loss $ (23,946) $ (11,279) $ (83,149) $ (8,312)
Net loss per share - basic $ (0.22) $ (0.19) $ (1.04) $ (0.14)
Net loss per share - diluted $ (0.22) $ (0.19) $ (1.04) $ (0.14)
Weighted average shares of common stock outstanding - basic 110,849,196 59,657,677 80,127,701 58,018,550
Weighted average shares of common stock outstanding - diluted 110,849,196 59,657,677 80,127,701 58,018,550